{"altmetric_id":22124809,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":24},"twitter":{"unique_users_count":14,"unique_users":["DrRaphaMoreira","sitcancer","ChrisHeery","SMVImmunology","YoungChris27040","GangFighterKy2","dreandea","darioT_","LizGifford3","putratidar79","CarlosHTonco","Ariltojr","HAOC_Onco","DrRiadYounes"],"posts_count":24}},"selected_quotes":["Very interesting. Another hypothesis: reduction of tumor mass reduces suppressive cytokines (TGF-beta, IL-6, IL-8)."],"citation":{"abstract":"Spontaneous regression of metastatic melanoma and delayed responses more than one year after treatment with ipilimumab are rarely seen.\nHere, we present the case of a patient with in transit metastases from cutaneous melanoma on his right lower extremity who achieved complete regression of all metastatic lesions 13\u00a0months after the first of two consecutive palliative resections of dominant masses and more than two years after treatment with ipilimumab.\nThe exact cause of our patient's sudden onset of tumor regression remains speculative. We hypothesize that the operative trauma followed by the postoperative infections augmented an innate immune response.","altmetric_jid":"52d3ea2986a3487b7e8b461a","authors":["Raphael B. Moreira","Lana Hamieh","Evisa Gjini","Ana Lako","Katherine M. Krajewski","Charles H. Yoon","Patrick A. Ott"],"doi":"10.1186\/s40425-017-0259-9","first_seen_on":"2017-07-18T16:02:16+00:00","funders":["niehs"],"handles":[],"issns":["2051-1426"],"issue":"1","journal":"Journal for Immunotherapy of Cancer","last_mentioned_on":1502919740,"links":["https:\/\/jitc.biomedcentral.com\/articles\/10.1186\/s40425-017-0259-9?platform=hootsuite","https:\/\/jitc.biomedcentral.com\/articles\/10.1186\/s40425-017-0259-9"],"pdf_url":"https:\/\/jitc.biomedcentral.com\/track\/pdf\/10.1186\/s40425-017-0259-9?site=jitc.biomedcentral.com","pmcid":"PMC5514538","pmid":"28716097","pubdate":"2017-07-18T00:00:00+00:00","publisher":"BioMed Central","startpage":"61","title":"Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2\u00a0years after treatment with ipilimumab","type":"article","volume":"5","mendeley_url":"http:\/\/www.mendeley.com\/research\/regression-multifocoal-transit-melanoma-metastases-after-palliative-resection-dominant-masses-2years"},"altmetric_score":{"score":8.6,"score_history":{"1y":8.6,"6m":8.6,"3m":8.6,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.6},"context_for_score":{"all":{"total_number_of_other_articles":8386076,"mean":7.0651873001299,"rank":1049284,"this_scored_higher_than_pct":87,"this_scored_higher_than":7334825,"rank_type":"exact","sample_size":8386076,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":216877,"mean":12.957412392335,"rank":39535,"this_scored_higher_than_pct":81,"this_scored_higher_than":177236,"rank_type":"exact","sample_size":216877,"percentile":81},"this_journal":{"total_number_of_other_articles":330,"mean":21.216571428571,"rank":71,"this_scored_higher_than_pct":78,"this_scored_higher_than":258,"rank_type":"exact","sample_size":330,"percentile":78},"similar_age_this_journal_3m":{"total_number_of_other_articles":27,"mean":11.003076923077,"rank":13,"this_scored_higher_than_pct":51,"this_scored_higher_than":14,"rank_type":"exact","sample_size":27,"percentile":51}}},"demographics":{"poster_types":{"member_of_the_public":5,"researcher":2,"practitioner":5,"science_communicator":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":5,"Science communicators (journalists, bloggers, editors)":2,"Scientists":2,"Members of the public":5}},"mendeley":{"by_status":{"Unspecified":1},"by_discipline":{"Unspecified":1}}},"geo":{"twitter":{"BR":5,"US":2,"CA":1,"AU":1,"IT":1,"GB":1,"ID":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/DrRaphaMoreira\/statuses\/896880199329099777","license":"gnip","citation_ids":[22124809],"posted_on":"2017-08-13T23:44:37+00:00","author":{"name":"Raphael Brand\u00e3o, MD","url":"http:\/\/www.instituto-oncoclinicas.org.br","image":"https:\/\/pbs.twimg.com\/profile_images\/753423683188731904\/SGquRUvF_normal.jpg","description":"VP, Chief Scientific Officer, Oncoclinicas Institute. Faculty member of Hospital Alem\u00e3o Oswaldo Cruz and CPO. Former fellow at @DanaFarber","id_on_source":"DrRaphaMoreira","tweeter_id":"111087196","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":281},"tweet_id":"896880199329099777"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/887322361430761472","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-18T14:45:11+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"887322361430761472"},{"url":"http:\/\/twitter.com\/ChrisHeery\/statuses\/887738150596096005","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-19T18:17:23+00:00","author":{"name":"Christopher Heery","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000728197658\/3c574b727c2153006d1cdb989299948e_normal.jpeg","description":"Medical Immuno-Oncologist, Translational Clinical Trials. In pursuit of cure. Tweets are my opinions and do not represent NCI.","id_on_source":"ChrisHeery","tweeter_id":"2189156778","followers":611},"tweet_id":"887738150596096005"},{"url":"http:\/\/twitter.com\/SMVImmunology\/statuses\/887739404164509709","license":"gnip","rt":["ChrisHeery"],"citation_ids":[22124809],"posted_on":"2017-07-19T18:22:22+00:00","author":{"name":"Saman Maleki, PhD","url":"http:\/\/samanmaleki.blogspot.ca\/","image":"https:\/\/pbs.twimg.com\/profile_images\/865578727203381248\/K582B1rK_normal.jpg","description":"Tumor Immunologist and Cancer Biologist @lawsonresearch. Advocate for Cancer Immunotherapy. Views are my own. Retweets or likes are not endorsement.","id_on_source":"SMVImmunology","tweeter_id":"397025602","geo":{"lt":42.98339,"ln":-81.23304,"country":"CA"},"followers":759},"tweet_id":"887739404164509709"},{"url":"http:\/\/twitter.com\/YoungChris27040\/statuses\/887869321032028160","license":"gnip","rt":["ChrisHeery"],"citation_ids":[22124809],"posted_on":"2017-07-20T02:58:36+00:00","author":{"name":"Chris Young","url":"https:\/\/m.facebook.com\/home.php?soft=bookmarks","image":"https:\/\/pbs.twimg.com\/profile_images\/832595198987296769\/VjFKip8q_normal.jpg","description":"Advocate #equality #disabilities #health LT #investor \ud83d\udd0eP-value mrkt intel\" #Biotech paradigm-shift research, pre-eminently humane. retweets not endorsements.","id_on_source":"YoungChris27040","tweeter_id":"1415149603","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":1366},"tweet_id":"887869321032028160"},{"url":"http:\/\/twitter.com\/GangFighterKy2\/statuses\/887984588756205568","license":"gnip","rt":["ChrisHeery"],"citation_ids":[22124809],"posted_on":"2017-07-20T10:36:38+00:00","author":{"name":"\u30e8\u30c3\u30b7\u30fc","image":"https:\/\/pbs.twimg.com\/profile_images\/716999221375709184\/YYOpmYfx_normal.jpg","description":"MD, Basic Researcher & Artist","id_on_source":"GangFighterKy2","tweeter_id":"714431915965571072","geo":{"lt":null,"ln":null},"followers":81},"tweet_id":"887984588756205568"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/888076067730321412","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-20T16:40:08+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"888076067730321412"},{"url":"http:\/\/twitter.com\/dreandea\/statuses\/888095571944382464","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-07-20T17:57:39+00:00","author":{"name":"Andrea Rindo","image":"https:\/\/pbs.twimg.com\/profile_images\/563329614286950400\/TvfK49uA_normal.jpeg","description":"Managing Editor for the Journal for ImmunoTherapy of Cancer (JITC) who loves singing, traveling, painting, breathing, gaming and cats. Opinions are my own.","id_on_source":"dreandea","tweeter_id":"239911563","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":231},"tweet_id":"888095571944382464"},{"url":"http:\/\/twitter.com\/darioT_\/statuses\/888107404591636480","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-07-20T18:44:40+00:00","author":{"name":"Dario Trapani","url":"http:\/\/www.medicinformazione.it\/Home.xhtml","image":"https:\/\/pbs.twimg.com\/profile_images\/881640305585475588\/RZg5Y0wW_normal.jpg","description":"medical #Oncology. Interested in translational medicine, new drugs & low-middle income Countries cancer-programs. University of Milan\/IEO.","id_on_source":"darioT_","tweeter_id":"1718379914","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":766},"tweet_id":"888107404591636480"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/888770639611428864","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-22T14:40:07+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"888770639611428864"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/890295696544464901","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-26T19:40:09+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"890295696544464901"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/891760345701908480","license":"gnip","citation_ids":[22124809],"posted_on":"2017-07-30T20:40:09+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"891760345701908480"},{"url":"http:\/\/twitter.com\/LizGifford3\/statuses\/891761611270238208","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-07-30T20:45:10+00:00","author":{"name":"Liz Gifford","image":"https:\/\/pbs.twimg.com\/profile_images\/739422830933245952\/BEVBW1b__normal.jpg","description":"I'm a busy CNS working with Advanced Melanoma cancer patients. Exciting times regarding new & novel therapies.Studying MSc in Clinical Leadership, help me","id_on_source":"LizGifford3","tweeter_id":"739418546531356673","geo":{"lt":50.72048,"ln":-1.8795,"country":"GB"},"followers":25},"tweet_id":"891761611270238208"},{"url":"http:\/\/twitter.com\/dreandea\/statuses\/892075695119245312","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-07-31T17:33:14+00:00","author":{"name":"Andrea Rindo","image":"https:\/\/pbs.twimg.com\/profile_images\/563329614286950400\/TvfK49uA_normal.jpeg","description":"Managing Editor for the Journal for ImmunoTherapy of Cancer (JITC) who loves singing, traveling, painting, breathing, gaming and cats. Opinions are my own.","id_on_source":"dreandea","tweeter_id":"239911563","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":231},"tweet_id":"892075695119245312"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/894236660967383040","license":"gnip","citation_ids":[22124809],"posted_on":"2017-08-06T16:40:08+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"894236660967383040"},{"url":"http:\/\/twitter.com\/dreandea\/statuses\/894741797687234560","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-08-08T02:07:22+00:00","author":{"name":"Andrea Rindo","image":"https:\/\/pbs.twimg.com\/profile_images\/563329614286950400\/TvfK49uA_normal.jpeg","description":"Managing Editor for the Journal for ImmunoTherapy of Cancer (JITC) who loves singing, traveling, painting, breathing, gaming and cats. Opinions are my own.","id_on_source":"dreandea","tweeter_id":"239911563","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":231},"tweet_id":"894741797687234560"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/896078815599804416","license":"gnip","citation_ids":[22124809],"posted_on":"2017-08-11T18:40:12+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"896078815599804416"},{"url":"http:\/\/twitter.com\/putratidar79\/statuses\/896351868212752384","license":"gnip","rt":["sitcancer"],"citation_ids":[22124809],"posted_on":"2017-08-12T12:45:13+00:00","author":{"name":"Rambo Bali","image":"https:\/\/pbs.twimg.com\/profile_images\/781887650449924096\/0puWNaWy_normal.jpg","description":"Simple me","id_on_source":"putratidar79","tweeter_id":"728176322049015808","geo":{"lt":-8.5,"ln":115,"country":"ID"},"followers":290},"tweet_id":"896351868212752384"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/897082160171143169","license":"gnip","rt":["DrRaphaMoreira"],"citation_ids":[22124809],"posted_on":"2017-08-14T13:07:08+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"897082160171143169"},{"url":"http:\/\/twitter.com\/sitcancer\/statuses\/897121966888562689","license":"gnip","citation_ids":[22124809],"posted_on":"2017-08-14T15:45:19+00:00","author":{"name":"SITC","url":"http:\/\/www.sitcancer.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/798183696943771648\/hV8wUbo5_normal.jpg","description":"Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.","id_on_source":"sitcancer","tweeter_id":"582208181","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":3467},"tweet_id":"897121966888562689"},{"url":"http:\/\/twitter.com\/CarlosHTonco\/statuses\/897134363506348032","license":"gnip","rt":["DrRaphaMoreira"],"citation_ids":[22124809],"posted_on":"2017-08-14T16:34:34+00:00","author":{"name":"Carlos Henrique","image":"https:\/\/pbs.twimg.com\/profile_images\/892196049108041730\/oxBoiWuu_normal.jpg","id_on_source":"CarlosHTonco","tweeter_id":"832340622476472320","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":89},"tweet_id":"897134363506348032"},{"url":"http:\/\/twitter.com\/Ariltojr\/statuses\/897197481032921088","license":"gnip","rt":["DrRaphaMoreira"],"citation_ids":[22124809],"posted_on":"2017-08-14T20:45:23+00:00","author":{"name":"Arilto Silva Jr","image":"https:\/\/pbs.twimg.com\/profile_images\/871806958940155906\/rdV1y9yd_normal.jpg","id_on_source":"Ariltojr","tweeter_id":"61339860","geo":{"lt":-19.92083,"ln":-43.93778,"country":"BR"},"followers":38},"tweet_id":"897197481032921088"},{"url":"http:\/\/twitter.com\/HAOC_Onco\/statuses\/897768542778646529","license":"gnip","rt":["DrRaphaMoreira"],"citation_ids":[22124809],"posted_on":"2017-08-16T10:34:34+00:00","author":{"name":"Centro de Oncologia","url":"http:\/\/centrodeoncologia.org.br","image":"https:\/\/pbs.twimg.com\/profile_images\/848215430049267712\/7kXkXiqT_normal.jpg","description":"Centro de Oncologia do Hospital Alem\u00e3o Oswaldo Cruz","id_on_source":"HAOC_Onco","tweeter_id":"829006073558339593","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":164},"tweet_id":"897768542778646529"},{"url":"http:\/\/twitter.com\/DrRiadYounes\/statuses\/897936588709273600","license":"gnip","rt":["DrRaphaMoreira"],"citation_ids":[22124809],"posted_on":"2017-08-16T21:42:20+00:00","author":{"name":"Riad Younes","image":"https:\/\/pbs.twimg.com\/profile_images\/829354159170281473\/aQIJ1SDL_normal.jpg","description":"Cirurgi\u00e3o, Diretor Geral do Centro Oncol\u00f3gico do Hospital Alem\u00e3o Oswaldo Cruz","id_on_source":"DrRiadYounes","tweeter_id":"828239815430774784","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":204},"tweet_id":"897936588709273600"}]}}